Search Results - "PAGLIERANI, M"

Accuracy and Reproducibility of HER2 Status in Breast Cancer Using Immunohistochemistry: A Quality Control Study in Tuscany Evaluating the Impact of Updated 2013 ASCO/CAP Recommendations by Bianchi, S., Caini, S., Paglierani, M., Saieva, C., Vezzosi, V., Baroni, G., Simoni, A., Palli, D.

“…The correct identification of HER2-positive cases is a key point to provide the most appropriate therapy to breast cancer (BC) patients. We aimed at…”
Get full text

Growth inhibition and differentiation of human breast cancer cells by the PAFR antagonist WEB-2086 by CELLAI, C, LAURENZANA, A, VANNUCCHI, A. M, CAPORALE, R, PAGLIERANI, M, DI LOLLO, S, PANCRAZZI, A, PAOLETTI, F

“…WEB-2086 -- an antagonist of platelet-activating factor receptor (PAFR) with known anti-inflammatory, antiangiogenic and antileukaemic properties -- also…”
Get full text

Androgen‐responsive and ‐unresponsive prostate cancer cell lines respond differently to stimuli inducing neuroendocrine differentiation by Marchiani, S, Tamburrino, L, Nesi, G, Paglierani, M, Gelmini, S, Orlando, C, Maggi, M, Forti, G, Baldi, E

“…The treatment of advanced prostate cancer (CaP) with androgen deprivation therapy inevitably renders the tumours castration resistant and incurable. Under…”
Get full text

Analysis of protease-activated receptor-1 and -2 in human scar formation by Materazzi, S, Pellerito, S, Di Serio, C, Paglierani, M, Naldini, A, Ardinghi, C, Carraro, F, Geppetti, P, Cirino, G, Santucci, M, Tarantini, F, Massi, D

“…Protease‐activated receptor (PAR)‐1 and PAR‐2 are reported to contribute to the fibrotic process in a number of organs, including lung, liver, pancreas, and…”
Get full text

hERG1 channels are overexpressed in glioblastoma multiforme and modulate VEGF secretion in glioblastoma cell lines by Masi, A, Becchetti, A, Restano-Cassulini, R, Polvani, S, Hofmann, G, Buccoliero, A M, Paglierani, M, Pollo, B, Taddei, G L, Gallina, P, Di Lorenzo, N, Franceschetti, S, Wanke, E, Arcangeli, A

Get full text

Sclerosing variant of PEComa: report of a case and review of the literature by Santi, R, Franchi, A, Villari, D, Paglierani, M, Pepi, M, Danielli, D, Nicita, G, Nesi, G

“…Tumours of perivascular epithelioid cells (PEComas) are a heterogeneous group of uncommon mesenchymal neoplasms which exhibit a peculiar immunohistochemical…”
Get full text

HERG potassium channels are more frequently expressed in human endometrial cancer as compared to non-cancerous endometrium by CHERUBINI, A, TADDEI, G. L, BECCHETTI, A, ROSATI, B, WANKE, E, OLIVOTTO, M, ARCANGELI, A, CROCIANI, O, PAGLIERANI, M, BUCCOLIERO, A. M, FONTANA, L, NOCI, I, BORRI, P, BORRANI, E, GIACHI, M

“…HERG K(+)channels, besides contributing to regulate cardiac and neuronal excitability, are preferentially expressed in tumour cell lines of different…”
Get full text

Carcinomas of sweat glands: report of 60 cases by Urso, C, Bondi, R, Paglierani, M, Salvadori, A, Anichini, C, Giannini, A

“…Several aspects of sweat gland carcinomas (incidence, classification, diagnosis, and behavior) have not been definitively clarified and need to be studied…”
Get full text

A comparison of methods for the analysis of low abundance proteins in desmoid tumor cells by Picariello, L., Sala, S. Carbonell, Martineti, V., Gozzini, A., Aragona, P., Tognarini, I., Paglierani, M., Nesi, G., Brandi, M.L., Tonelli, F.

“…The desmoids are a group of rare clinically diverse, deep-seated fibrous neoplasms. The exact etiology is unknown, but several factors are considered to be…”
Get full text

Persistence of expression of the TMPRSS2:ERG fusion gene after pre-surgery androgen ablation may be associated with early prostate specific antigen relapse of prostate cancer: Preliminary results by Bonaccorsi, L., Nesi, G., Nuti, F., Paglierani, M., Krausz, C., Masieri, L., Serni, S., Proietti-Pannunzi, L., Fang, Y., Jhanwar, S. C., Orlando, C., Carini, M., Forti, G., Baldi, E., Luzzatto, L.

“…Background : The recently identified TM-PRSS2:ERG fusion gene is a candidate oncogene for prostate cancer (PCa). Subjects and methods : We have tested for the…”
Get full text

O6- Methylguanine-DNA-Methyltransferase in Recurring Anaplastic Ependymomas: PCR and Immunohistochemistry by Buccoliero, A.M., Castiglione, F., Rossi Degl'innocenti, D., Paglierani, M., Maio, V., Gheri, C.F., Garbini, F., Moncini, D., Taddei, A., Sardi, I., Sanzo, M., Giordano, F., Mussa, F., Genitori, L., Taddei, G.L.

“…Ependymomas are the third most common brain tumor in children. The post surgical management is controversial. There are no convincing data on an effective role…”
Get full text

Immunohistochemical and FISH analyses identify synovitis associated with chronic GVHD after allogeneic hematopoietic SCT by Nozzoli, C, Guidi, S, Paglierani, M, Wnekowicz, E, Saccardi, R, Bosi, A, Santucci, M, Massi, D

Get full text

Expression of protease-activated receptor-1 and -2 in orofacial granulomatosis by Ketabchi, S, Massi, D, Ficarra, G, Rubino, I, Franchi, A, Paglierani, M, Simoni, A, Capodiferro, S, Favia, G, Maiorano, E, Tarantini, F, Cirino, G, Santucci, M

“…Objective:  Orofacial granulomatosis (OFG) is a rare condition characterized by non‐caseating granulomas in the orofacial region. Protease‐Activated Receptors…”
Get full text

Inducible cyclooxygenase (COX-2) in glioblastoma--clinical and immunohistochemical (COX-2-VEGF) correlations by Buccoliero, A M, Caldarella, A, Gheri, C F, Taddei, A, Paglierani, M, Pepi, M, Mennonna, P, Taddei, G L

“…Cyclooxygenase-2 (COX-2) is the inducible form of the enzyme responsible for the first step in the prostaglandin synthesis. COX-2 upregulation is demonstrated…”
Get more information

Longstanding survival without cancer progression in a patient affected by endometrial carcinoma treated primarily with leuprolide by NOCI, I, BORRI, P, BONFIRRARO, G, CHIEFFI, O, ARCANGELI, A, CHERUBINI, A, DABIZZI, S, BUCCOLIERO, A. M, PAGLIERANI, M, TADDEI, G. L

“…We report here a case of a patient affected by endometrial cancer and treated primarily with leuprolide, the surgical approach being unfeasible due to her…”
Get full text

Expression and amplification of HER-2/neu oncogene in uterine carcinosarcomas: a marker for potential molecularly targeted treatment? by Raspollini, M R, Susini, T, Amunni, G, Paglierani, M, Castiglione, F, Garbini, F, Carriero, C, Scarselli, G, Taddei, G L

“…Surgery is the treatment of choice for uterine carcinosarcomas; nevertheless, the poor effect of chemotherapy and radiotherapy represents an insidious problem…”
Get more information

Prognostic significance of c-erbB-2 expression in node negative breast cancer by BIANCHI, S, PAGLIERANI, M, ZAMPI, G, CARDONA, G, CATALIOTTI, L, BONARDI, R, CIATTO, S

“…The prognostic value of c-erbB-2 oncogene expression was studied retrospectively in a consecutive series of 230 node negative breast cancers, followed-up for…”
Get full text

Cyclooxygenase-2 Expression in Uterine Leiomyosarcomas by Raspollini, M.R., Amunni, G., Villanucci, A., Paglierani, M., Taddei, G.L.

“…Many studies have focused on cyclooxygenase-2 (COX-2) alterations as a critical step in the onset and progression of cancer. Moreover, a strong correlation…”
Get full text

Instability at dinucleotide and trinucleotide repeats in breast cancer by Ottini, L, Palli, D, Falchetti, M, D'Amico, C, Noviello, C, Saieva, C, Russo, A, Corsi, A M, Masala, G, Paglierani, M, Vezzosi, V, Bianchi, S, Mariani-Costantini, R

“…We analyzed 7 mono-, 6 di- and 2 trinucleotide repeat loci in a well characterized series of 69 breast cancer cases, treated in the period 1985-1986 and…”
Get more information

C-kit Expression in Uterine Leiomyosarcomas: An Immunocytochemical Study of 29 Cases of Malignant Smooth Muscle Tumors of the Uterus by Raspollini, M.R., Villanucci, A., Amunni, G., Paglierani, M., Taddei, A., Taddei, G.L.

“…Uterine malignant stromal tumors are rare neoplasms characterized by fatal prognosis. At the moment no effective systemic treatment is available for…”
Get full text